Personal information

No personal information available

Activities

Collapse all

Employment (4)

Institut Curie: Saint-Cloud, Île-de-France, FR

2018-04-01 to present
Employment
Source: Self-asserted source
Anne-Sophie HAMY

Institut Curie: Saint Cloud, Île-de-France, FR

2013-09-16 to 2014-10-31 | MD (Medical oncology)
Employment
Source: Self-asserted source
Anne-Sophie HAMY

Assistance Publique - Hôpitaux de Paris: Paris, Île-de-France, FR

2009-11-02 to 2011-10-30 | Assistant Professor (Chef de clinique Assistant) (Breast disease Center, Hôpital Saint Louis)
Employment
Source: Self-asserted source
Anne-Sophie HAMY

Assistance Publique - Hôpitaux de Paris: Paris, Île-de-France, FR

2008-11-02 to 2009-10-30 | MD (Breast disease center, hôpital Saint Louis)
Employment
Source: Self-asserted source
Anne-Sophie HAMY

Education and qualifications (4)

Department of translational Research Institut Curie : Paris, 75, FR

2014-11-02 to present | MD, PhD student (RT2 Lab (Residual tumor and Response to treatment) )
Education
Source: Self-asserted source
Anne-Sophie HAMY

Université Paris-Sud: Orsay, Île-de-France, FR

2012-09-15 to 2013-06-30 | Master of sciences, Research in public health, clinical research
Education
Source: Self-asserted source
Anne-Sophie HAMY

Université Paris Descartes: Paris, Île-de-France, FR

2008-11-02 to 2009-10-30 | DESC oncology (post graduate diploma in complementary specialized studies)
Education
Source: Self-asserted source
Anne-Sophie HAMY

Université Paris Descartes: Paris, Île-de-France, FR

2004-11-02 to 2008-10-30 | Residence medical gynecology
Education
Source: Self-asserted source
Anne-Sophie HAMY

Funding (2)

Soutien pour la formation à la recherche translationnelle en cancérologie

2014-11 to 2017-10 | Contract
INSERM (Paris, Ile de France, FR)
GRANT_NUMBER: undefined id
Source: Self-asserted source
Anne-Sophie HAMY

Prix Albert and Alice Netter : OBAMA Study

2013 to present | Award
European Society Gynecology (Paris, FR)
GRANT_NUMBER: undefined id
Source: Self-asserted source
Anne-Sophie HAMY

Works (50 of 73)

Items per page:
Page 1 of 2

Explaining the Relationships Between Age, Endocrine Therapy Persistence, and Risk of Recurrence in Hormone Receptor–Positive Early Breast Cancer: A Nationwide Cohort Study

Journal of Clinical Oncology
2025-03-05 | Journal article
DOI: 10.1200/JCO.24.01131
Contributors: Elise Dumas; Floriane Jochum; Florence Coussy; Anne-Sophie Hamy; Alena Majdling; Sophie Houzard; Christine Le Bihan-Benjamin; Fabien Reyal; Paul Gougis; Mats Julius Stensrud
Source: check_circle
Crossref

Clinical Behavior of Breast Cancer in Young BRCA Carriers and Prediagnostic Awareness of Germline BRCA Status

Journal of Clinical Oncology
2025-02-24 | Journal article
DOI: 10.1200/JCO-24-01334
Contributors: Matteo Lambertini; Eva Blondeaux; Loredana M. Tomasello; Elisa Agostinetto; Anne-Sophie Hamy; Hee Jeong Kim; Maria Alice Franzoi; Rinat Bernstein-Molho; Florentine Hilbers; Katarzyna Pogoda et al.
Source: check_circle
Crossref

Characteristics and clinical outcomes of breast cancer in young BRCA carriers according to tumor histology

ESMO Open
2024-10 | Journal article
DOI: 10.1016/j.esmoop.2024.103714
Contributors: E. Agostinetto; M. Bruzzone; A.-S. Hamy; H.J. Kim; C. Chiodi; R. Bernstein-Molho; S. Linn; K. Pogoda; E. Carrasco; F. Derouane et al.
Source: check_circle
Crossref

Changes in physical activity, heart rate and sleep during the COVID-19 pandemic in 34 countries: A retrospective analysis using activity trackers (Preprint)

Journal of Medical Internet Research
2024-10-30 | Journal article
DOI: 10.2196/68199
Contributors: Bastien Wyatt; Nicolas Forstmann; Nolwenn Badier; Anne-Sophie Hamy; Quentin De Larochelambert; Juliana Antero; Arthur Danino; Vincent Vercamer; Paul De Villele; Benjamin Vittrant et al.
Source: check_circle
Crossref

Physical activity, heart rate and sleep before and during the COVID-19 pandemic in 34 countries (Preprint)

2024-10-30 | Preprint
DOI: 10.2196/preprints.68199
Contributors: Bastien Wyatt; Nicolas Forstmann; Nolwenn Badier; Anne-Sophie Hamy; Quentin De Larochelambert; Juliana Antero; Arthur Danino; Vincent Vercamer; Paul De Villele; Benjamin Vittrant et al.
Source: check_circle
Crossref

Vaginal estrogen therapy initiation after breast cancer and oncological outcomes: a nationwide population-based target trial emulation.

2024-10-24 | Preprint
DOI: 10.1101/2024.10.23.24315966
Contributors: Elise Dumas; Anne-Sophie Hamy; Paul Gougis; Enora Laas; Floriane Jochum; Diane Hill; Christine Rousset-Jablonski; Sophie El Ferjaoui; Philippe-Jean Bousquet; Sophie Houzard et al.
Source: check_circle
Crossref

Sex-related differences in oncological surgery and postoperative outcomes: comprehensive, nationwide study in France

British Journal of Surgery
2024-08-02 | Journal article
DOI: 10.1093/bjs/znae179
Contributors: Floriane Jochum; Anne-Sophie Hamy; Paul Gougis; Élise Dumas; Beatriz Grandal; Mathilde Sauzey; Enora Laas; Jean-Guillaume Feron; Virginie Fourchotte; Thomas Gaillard et al.
Source: check_circle
Crossref

Evolution of synchronous female bilateral breast cancers and response to treatment

Nature Medicine
2023-03 | Journal article
DOI: 10.1038/s41591-023-02216-8
Contributors: Anne-Sophie Hamy; Judith Abécassis; Keltouma Driouch; Lauren Darrigues; Mathias Vandenbogaert; Cecile Laurent; Francois Zaccarini; Benjamin Sadacca; Myriam Delomenie; Enora Laas et al.
Source: check_circle
Crossref

Evolution of contraceptive practices in France: An overview from 2014 to 2019

Gynécologie Obstétrique Fertilité & Sénologie
2022 | Journal article
DOI: 10.1016/J.GOFS.2022.04.005
WOSUID: WOS:000836578200006
Contributors: Donval, L.; Oufkir, N.; Bondu, D.; Daoud, E.; Dumas, E.; Reyal, F.; Hamy, A-S
Source: check_circle
Web of Science Researcher Profile Sync

Techniques and complications of non-genetic risk reducing mastectomies: Guidelines of the National College of French Gynecologists and Obstetricians (CNGOF)

Gynécologie Obstétrique Fertilité & Sénologie
2022 | Journal article
DOI: 10.1016/J.GOFS.2021.12.006
WOSUID: WOS:000753064000003
Contributors: Mathelin, C.; Barranger, E.; Boisserie-Lacroix, M.; Boutet, G.; Brousse, S.; Chabbert-Buffet, N.; Coutant, C.; Darai, E.; Delpech, Y.; Duraes, M. et al.
Source: check_circle
Web of Science Researcher Profile Sync

Impact of the Area of Residence of Ovarian Cancer Patients on Overall Survival

Cancers
2022-12-04 | Journal article
DOI: 10.3390/cancers14235987
Contributors: Floriane Jochum; Anne-Sophie Hamy; Thomas Gaillard; Lise Lecointre; Paul Gougis; Élise Dumas; Beatriz Grandal; Jean-Guillaume Feron; Enora Laas; Virginie Fourchotte et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

No Impact of Seasonality of Diagnoses on Baseline Tumor Immune Infiltration, Response to Treatment, and Prognosis in BC Patients Treated with NAC

Cancers
2022-06 | Journal article | Author
DOI: 10.3390/cancers14133080
Contributors: Beatriz Grandal; Ashwaq Aljehani; Elise Dumas; Eric Daoud; Floriane Jochum; Paul Gougis; Judicaël Hotton; Amélie Lemoine; Sophie Michel; Enora Laas et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Negative Relationship between Post-Treatment Stromal Tumor-Infiltrating Lymphocyte (TIL) and Survival in Triple-Negative Breast Cancer Patients Treated with Dose-Dense Dose-Intense NeoAdjuvant Chemotherapy

Cancers
2022-03 | Journal article | Author
DOI: 10.3390/cancers14051331
Contributors: Sylvie Giacchetti; Lilith Faucheux; Charlotte Gardair; Caroline Cuvier; Anne de Roquancourt; Luca Campedel; David Groheux; Cedric de Bazelaire; Jacqueline Lehmann-Che; Catherine Miquel et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Contraception in breast cancer survivors from the FEERIC case-control study (performed on behalf of the Seintinelles research network)

MedRxiv
2021 | Journal article
DOI: 10.1101/2021.12.15.21267867
WOSUID: PPRN:11357966
Contributors: Sebbag, C.; Rousset-Jablonski, C.; Coussy, F.; Ray-Coquard, I.; Garin, C.; Evrevin, C.; Toussaint, A.; Cessot, M.; Labrosse, J.; Laot, L. et al.
Source: check_circle
Web of Science Researcher Profile Sync

Safety of assisted reproductive techniques in young women harboring germline pathogenic variants in BRCA1/2 with a pregnancy after prior history of breast cancer

ESMO Open
2021-12 | Journal article
DOI: 10.1016/j.esmoop.2021.100300
Contributors: M. Condorelli; M. Bruzzone; M. Ceppi; A. Ferrari; A. Grinshpun; A.S. Hamy; E. de Azambuja; E. Carrasco; F.A. Peccatori; A. Di Meglio et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Evolution of synchronous bilateral breast cancers provide insights into interactions between host, tumor and immunity

2021-12-29 | Preprint
DOI: 10.1101/2021.12.28.21267674
Contributors: Anne-Sophie Hamy; Judith Abecassis; Lauren Darrigues; Cecile Laurent; François Zaccarini; Benjamin Sadacca; Myriam Delomenie; Enora Laas; Odette Mariani; Thanh Lam et al.
Source: check_circle
Crossref

CAMION: a catchment area maximization algorithm, with application to oncology accessibility in metropolitan France

2021-10-01 | Preprint
DOI: 10.1101/2021.09.29.21264296
Contributors: Eric Daoud; Anne-Sophie Hamy; Elise Dumas; Lidia Delrieu; Beatriz Grandal Rejo; Christine Le Bihan-Benjamin; Sophie Houzard; Philippe-Jean Bousquet; Judicaël Hotton; Aude-Marie Savoye et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Breast Cancer (BC) Is a Window of Opportunity for Smoking Cessation: Results of a Retrospective Analysis of 1234 BC Survivors in Follow-Up Consultation

Cancers
2021-05 | Journal article | Author
DOI: 10.3390/cancers13102423
Contributors: Marion Nicolas; Beatriz Grandal; Emma Dubost; Amyn Kassara; Julien Guerin; Aullene Toussaint; Enora Laas; Jean-Guillaume Feron; Virginie Fourchotte; Fabrice Lecuru et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Time to Pregnancy, Obstetrical and Neonatal Outcomes after Breast Cancer: A Study from the Maternity Network for Young Breast Cancer Patients

Cancers
2021-03 | Journal article | Author
DOI: 10.3390/cancers13051070
Contributors: Julie Labrosse; Anne Lecourt; Alice Hours; Clara Sebbag; Aullene Toussaint; Enora Laas; Florence Coussy; Beatriz Grandal; Elise Dumas; Eric Daoud et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Patterns of Sequelae in Women with a History of Localized Breast Cancer: Results from the French VICAN Survey

Cancers
2021-03-08 | Journal article
DOI: 10.3390/cancers13051161
Contributors: Lidia Delrieu; Liacine Bouaoun; Douae El Fatouhi; Elise Dumas; Anne-Deborah Bouhnik; Hugo Noelle; Emmanuelle Jacquet; Anne-Sophie Hamy; Florence Coussy; Fabien Reyal et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

PD-L1 Expression after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancers Is Associated with Aggressive Residual Disease, Suggesting a Potential for Immunotherapy

Cancers
2021-02 | Journal article | Author
DOI: 10.3390/cancers13040746
Contributors: Beatriz Grandal; Manon Mangiardi-Veltin; Enora Laas; Marick Laé; Didier Meseure; Guillaume Bataillon; Elsy El-Alam; Lauren Darrigues; Elise Dumas; Eric Daoud et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Clinical behavior and outcomes of breast cancer in young women with germline BRCA pathogenic variants

npj Breast Cancer
2021-02-12 | Journal article
DOI: 10.1038/s41523-021-00224-w
Contributors: Matteo Lambertini; Marcello Ceppi; Anne-Sophie Hamy; Olivier Caron; Philip D. Poorvu; Estela Carrasco; Albert Grinshpun; Kevin Punie; Christine Rousset-Jablonski; Alberta Ferrari et al.
Source: check_circle
Crossref

Body Mass Index and Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer

JNCI: Journal of the National Cancer Institute
2021-02-01 | Journal article
DOI: 10.1093/jnci/djaa090
Contributors: Giuseppe Floris; François Richard; Anne-Sophie Hamy; Lynn Jongen; Hans Wildiers; Jan Ardui; Kevin Punie; Ann Smeets; Patrick Berteloot; Ignace Vergote et al.
Source: check_circle
Crossref

<i>HER2</i>-Positive Breast Cancer Patients with Pre-Treatment Axillary Involvement or Postmenopausal Status Benefit from Neoadjuvant Rather than Adjuvant Chemotherapy Plus Trastuzumab Regimens

Cancers
2021-01 | Journal article | Author
DOI: 10.3390/cancers13030370
Contributors: Enora Laas; Arnaud Bresset; Jean-Guillaume Féron; Claire Le Gal; Lauren Darrigues; Florence Coussy; Beatriz Grandal; Lucie Laot; Jean-Yves Pierga; Fabien Reyal et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

The Presence of an In Situ Component on Pre-Treatment Biopsy Is Not Associated with Response to Neoadjuvant Chemotherapy for Breast Cancer

Cancers
2021-01-10 | Journal article
DOI: 10.3390/cancers13020235
Contributors: Julie Labrosse; Charlotte Morel; Thanh Lam; Enora Laas; Jean-Guillaume Feron; Florence Coussy; Marick Lae; Fabien Reyal; Anne-Sophie Hamy
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Prognostic Impact of Stromal Immune Infiltration before and after Neoadjuvant Chemotherapy (NAC) in Triple Negative Inflammatory Breast Cancers (TNIBC) Treated with Dose-Dense Dose-Intense NAC

Cancers
2020-09 | Journal article | Author
DOI: 10.3390/cancers12092657
Contributors: Luca Campedel; Paul Blanc-Durand; Asker Bin Asker; Jacqueline Lehmann-Che; Caroline Cuvier; Cedric De Bazelaire; Luis Teixeira; Stephanie Becourt; Florence Ledoux; Hamid Hocini et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Fertility preservation in young breast cancer patients: Real life data on 1390 patients treated in the Institut Curie

Cancer Research
2019 | Journal article
DOI: 10.1158/1538-7445.SABCS18-P6-16-02
WOSUID: WOS:000478677002261
Contributors: Hamy-Petit, A-S; Toussaint, A.; Sautter, C.; Coussy, F.; Donnadieu, A.; Rouzier, R.; Saule, C.; Frank, S.; Bensen, A.; Grynberg, M. et al.
Source: check_circle
Web of Science Researcher Profile Sync

Interaction between molecular subtype and stromal immune infiltration dynamics in breast cancer patients treated with neoadjuvant chemotherapy

Cancer Research
2019 | Journal article
DOI: 10.1158/1538-7445.SABCS18-P3-11-01
WOSUID: WOS:000478677001216
Contributors: Hamy, A-S; Bonsang-Kitzis, H.; De Croze, D.; Laas, E.; Darrigues, L.; Topciu, L.; Menet, E.; Vincent-Salomon, A.; Lerebours, F.; Pierga, J-Y et al.
Source: check_circle
Web of Science Researcher Profile Sync

Interaction between molecular subtypes, stromal immune infiltration before and after treatment in breast cancer patients treated with neoadjuvant chemotherapy

Clinical Cancer Research
2019-09-12 | Journal article
DOI: 10.1158/1078-0432.CCR-18-3017
Contributors: Anne-Sophie Hamy; Hélène Bonsang-Kitzis; Diane De Croze; Enora Laas; Lauren Darrigues; Lucian Topciu; Emmanuelle Menet; Anne Vincent-Salomon; Florence Lerebours; Jean-Yves Pierga et al.
Source: check_circle
Crossref

A multivariate Th17 metagene for prognostic stratification in T cell non-inflamed triple negative breast cancer

OncoImmunology
2019-09-02 | Journal article
DOI: 10.1080/2162402X.2019.1624130
Contributors: L. Faucheux; M. Grandclaudon; M. Perrot-Dockès; P. Sirven; F. Berger; A.S. Hamy; V. Fourchotte; A. Vincent-Salomon; F. Mechta-Grigoriou; F. Reyal et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Neoadjuvant treatment for intermediate/high-risk HER2-positive and triple-negative breast cancers: no longer an ‘option’ but an ethical obligation

ESMO Open
2019-05 | Journal article
DOI: 10.1136/esmoopen-2019-000515
Contributors: Mariana Brandão; Fabien Reyal; Anne-Sophie Hamy; Martine Piccart-Gebhart
Source: check_circle
Crossref

Neoadjuvant treatment: the future of patients with breast cancer

ESMO Open
2018 | Journal article
DOI: 10.1136/ESMOOPEN-2018-000371
WOSUID: WOS:000434880000006
Contributors: Reyal, F.; Hamy, A. S.; Piccart, Martine J.
Source: check_circle
Web of Science Researcher Profile Sync

Assessing reliability of intra-tumor heterogeneity estimates from single sample whole exome sequencing data

2018-10-11 | Other
DOI: 10.1101/440750
Contributors: Judith Abécassis; Anne-Sophie Hamy; Cécile Laurent; Benjamin Sadacca; Hélène Bonsang-Kitzis; Fabien Reyal; Jean-Philippe Vert
Source: check_circle
Crossref

Stromal lymphocyte infiltration after neoadjuvant chemotherapy is associated with aggressive residual disease and lower disease-free survival in HER2-positive breast cancer

Annals of Oncology
2017 | Journal article
DOI: 10.1093/ANNONC/MDX309
WOSUID: WOS:000409376200029
Contributors: Hamy, A. -S.; Pierga, J. -Y.; Sabaila, A.; Laas, E.; Bonsang-Kitzis, H.; Laurent, C.; Vincent-Salomon, A.; Cottu, P.; Lerebours, F.; Rouzier, R. et al.
Source: check_circle
Web of Science Researcher Profile Sync

Biological network-driven gene selection identifies a stromal immune module as a key determinant of triple-negative breast carcinoma prognosis

OncoImmunology
2016 | Journal article
DOI: 10.1080/2162402X.2015.1061176
WOSUID: WOS:000373383600005
Contributors: Bonsang-Kitzis, H.; Sadacca, B.; Hamy-Petit, A. S.; Moarii, M.; Pinheiro, A.; Laurent, C.; Reyal, F.
Source: check_circle
Web of Science Researcher Profile Sync

BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy

Breast Cancer Research and Treatment
2016 | Journal article
DOI: 10.1007/S10549-016-3961-2
WOSUID: WOS:000383613100010
Contributors: Hamy, A. S.; Bieche, I.; Lehmann-Che, J.; Scott, V.; Bertheau, Ph.; Guinebretiere, J. M.; Matthieu, M. C.; Sigal-Zafrani, B.; Tembo, O.; Marty, M. et al.
Source: check_circle
Web of Science Researcher Profile Sync

Identification of a predictive and prognostic immune stromal module associated with lymphocytic infiltrate in HER2-positive breast cancers Abstracts

Bulletin du Cancer
2016 | Journal article
WOSUID: WOS:000388729300020
Contributors: Hamy-Petit, A-S.; Bonsang-Kitzis, H.; Lae, M.; Moarii, M.; Sadacca, B.; Abecassis, J.; Pinheiro, A.; Galliot, M.; Laurent, C.; Reyal, F.
Source: check_circle
Web of Science Researcher Profile Sync

Long term survival of locally advanced breast cancers (LABC) treated with neoadjuvant treatment, results of a multicenter randomised phase II study (Remagus 02 trial)

Cancer Research
2016 | Journal article
DOI: 10.1158/1538-7445.SABCS15-P1-14-09
WOSUID: WOS:000375622400327
Contributors: Giacchetti, S.; Hamy-Petit, A-S; Delaloge, S.; Brain, E.; Berger, F.; Mathieu, M-C; de Cremoux, P.; Bertheau, P.; Guinebretiere, J-M; Saghatchian, M. et al.
Source: check_circle
Web of Science Researcher Profile Sync

Prediction of pathological response (pCR) to neoadjuvant dose dense and intense cyclophosphamide and anthracycline in a prospective series of triple negative locally advanced breast cancers (TNLABC)

Cancer Research
2016 | Journal article
DOI: 10.1158/1538-7445.SABCS15-P1-14-08
WOSUID: WOS:000375622400326
Contributors: Giacchetti, S.; De Roquancourt, A.; Groheux, D.; Piron, P.; Lehmann-che, J.; Cuvier, C.; Resche-rigon, M.; Albiter, M.; Roche, B.; Frank, S. et al.
Source: check_circle
Web of Science Researcher Profile Sync

A Stromal Immune Module Correlated with the Response to Neoadjuvant Chemotherapy, Prognosis and Lymphocyte Infiltration in HER2-Positive Breast Carcinoma Is Inversely Correlated with Hormonal Pathways

PLOS ONE
2016-12-22 | Journal article
DOI: 10.1371/journal.pone.0167397
Contributors: Anne-Sophie Hamy; William B. Coleman; Hélène Bonsang-Kitzis; Marick Lae; Matahi Moarii; Benjamin Sadacca; Alice Pinheiro; Marion Galliot; Judith Abecassis; Cecile Laurent et al.
Source: check_circle
Crossref

Anti-Müllerian hormone in breast cancer patients treated with chemotherapy: a retrospective evaluation of subsequent pregnancies

Reproductive BioMedicine Online
2016-03 | Journal article
DOI: 10.1016/j.rbmo.2015.12.008
Contributors: Anne-Sophie Hamy; Raphaël Porcher; Sarah Eskenazi; Caroline Cuvier; Sylvie Giacchetti; Florence Coussy; Hamid Hocini; Bertrand Tournant; Francine Perret; Sylvie Bonfils et al.
Source: check_circle
Crossref

Prognostic impact of 18F-FDG PET/CT staging and of pathological response to neoadjuvant chemotherapy in triple-negative breast cancer.

2015-03 | Journal article
DOI:

10.1007/s00259-014-2941-1

PMID:

25432784
Contributors: Groheux D; Giacchetti S; Delord M; de Roquancourt A; Merlet P; Hamy AS; Espié M; Hindié E
Source: Self-asserted source
Anne-Sophie HAMY via Europe PubMed Central
grade
Preferred source (of 2)‎

Contraception after breast cancer: a retrospective review of the practice among French Gynecologists in the 2000's

European Journal of Gynaecological Oncology
2014 | Journal article
WOSUID: WOS:000341554600010
Contributors: Hamy, A. S.; Abuellellah, H.; Hocini, H.; Coussy, F.; Gorins, A.; Serfaty, D.; Tournant, B.; Perret, F.; Bonfils, S.; Giacchetti, S. et al.
Source: check_circle
Web of Science Researcher Profile Sync

Contraception after breast cancer: a retrospective review of the practice among French gynecologists in the 2000's.

2014 | Journal article
PMID:

24772917
Contributors: Hamy AS; Abuellellah H; Hocini H; Coussy F; Gorins A; Serfaty D; Tournant B; Perret F; Bonfils S; Giacchetti S et al.
Source: Self-asserted source
Anne-Sophie HAMY via Europe PubMed Central

Ovarian reserve in breast cancer: assessment with anti-Mullerian hormone.

2014-11 | Journal article
DOI:

10.1016/j.rbmo.2014.07.008

PMID:

25246112
Contributors: Hamy AS; Porcher R; Cuvier C; Giacchetti S; Schlageter MH; Coussieu C; Gronier H; Feugeas JP; Adoui N; Lacorte JM et al.
Source: Self-asserted source
Anne-Sophie HAMY via Europe PubMed Central
grade
Preferred source (of 2)‎

Early assessment with 18F-fluorodeoxyglucose positron emission tomography/computed tomography can help predict the outcome of neoadjuvant chemotherapy in triple negative breast cancer.

2014-07 | Journal article
DOI:

10.1016/j.ejca.2014.04.020

PMID:

24841218
Contributors: Groheux D; Hindié E; Giacchetti S; Hamy AS; Berger F; Merlet P; de Roquancourt A; de Cremoux P; Marty M; Hatt M et al.
Source: Self-asserted source
Anne-Sophie HAMY via Europe PubMed Central

Long-term survival of advanced triple-negative breast cancers with a dose-intense cyclophosphamide/anthracycline neoadjuvant regimen.

2014-03 | Journal article
DOI:

10.1038/bjc.2014.81

PMID:

24569467

PMC:

PMC3960631
Contributors: Giacchetti S; Porcher R; Lehmann-Che J; Hamy AS; de Roquancourt A; Cuvier C; Cottu PH; Bertheau P; Albiter M; Bouhidel F et al.
Source: Self-asserted source
Anne-Sophie HAMY via Europe PubMed Central
grade
Preferred source (of 2)‎

Correlation between MRI and biopsies under second look ultrasound.

2014-02 | Journal article
DOI:

10.1016/j.diii.2014.01.005

PMID:

24525086
Contributors: Nouri-Neuville M; de Rocquancourt A; Cohen-Zarade S; Chapellier-Canaud M; Albiter M; Hamy AS; Giachetti S; Cuvier C; Espié M; de Kerviler É et al.
Source: Self-asserted source
Anne-Sophie HAMY via Europe PubMed Central
grade
Preferred source (of 2)‎

Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15.

2013 | Journal article
DOI:

10.1186/bcr3421

PMID:

23663520

PMC:

PMC4053236
Contributors: Lehmann-Che J; Hamy AS; Porcher R; Barritault M; Bouhidel F; Habuellelah H; Leman-Detours S; de Roquancourt A; Cahen-Doidy L; Bourstyn E et al.
Source: Self-asserted source
Anne-Sophie HAMY via Europe PubMed Central

Hormone replacement therapy, is there an increased risk of in situ breast cancer ? data from a french cohort

Cancer Research
2012 | Journal article
DOI: 10.1158/0008-5472.SABCS12-P4-13-03
WOSUID: WOS:000209704901018
Contributors: Coussy, F.; Giacchetti, S.; Hamy, A-S; Porcher, R.; Cuvier, C.; Lalloum, M.; de Roquancourt, A.; Albiter, M.; Espie, M.
Source: check_circle
Web of Science Researcher Profile Sync
Items per page:
Page 1 of 2

Peer review (1 review for 1 publication/grant)

Review activity for Nature medicine. (1)
How many people are using ORCID?